<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35437959</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2466-054X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>63</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>Investigative and clinical urology</Title>
          <ISOAbbreviation>Investig Clin Urol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Catheter-associated urinary tract infections in patients who have undergone radical cystectomy for bladder cancer: A prospective randomized clinical study of two silicone catheters (clinical benefit of antibiotic silicone material).</ArticleTitle>
        <Pagination>
          <StartPage>334</StartPage>
          <EndPage>340</EndPage>
          <MedlinePgn>334-340</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.4111/icu.20210436</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE">The prevalence of catheter-associated urinary tract infections (CAUTIs) varies from 5% to 8.2%, and the risk of infection increases by 5% to 7% per day of primary indwelling. We investigated whether a novel biofilm inhibitory mechanism using an inhibitory silicone urethral catheter (a coated Foley catheter) can reduce CAUTIs compared to conventional non-coated Foley catheters.</AbstractText>
          <AbstractText Label="MATERIALS AND METHODS">This study prospectively analyzed the difference in the incidence of CAUTIs in patients who underwent radical cystectomy with an orthotopic neobladder for bladder cancer and received a coated or conventional non-coated catheter. Additionally, differences in bacterial colonization between the groups were analyzed using a catheter-tip bacterial culture test.</AbstractText>
          <AbstractText Label="RESULTS">Eighty-five patients were randomized into the "coated Foley catheter" group (abbreviated as "case" group; 41 patients) and a control group (44 patients). The two groups were identical except for their surgical history. The incidence of CAUTIs 2 weeks after radical cystectomy was 21.95% (case) and 27.27% (control), with no significant difference between the two groups. However, when the catheter was removed 2 weeks after surgery, the catheter tip culture test revealed significant bacterial colonies in 25 (60.98%) and 38 (86.36%) patients in the case and control group, respectively. No catheter-related postoperative side effects were observed in either group.</AbstractText>
          <AbstractText Label="CONCLUSIONS">The incidence of CAUTIs in the two groups did not differ according to the catheter material. However, the catheter bacterial culture test showed that bacterial colonization was significantly suppressed on the Bi-Fi Free technology catheter, which comparatively inhibited biofilm formation.</AbstractText>
          <CopyrightInformation>© The Korean Urological Association.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Tae</LastName>
            <ForeName>Bum Sik</ForeName>
            <Initials>BS</Initials>
            <Identifier Source="ORCID">0000-0003-2963-7366</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Urology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Oh</LastName>
            <ForeName>Jong Jin</ForeName>
            <Initials>JJ</Initials>
            <Identifier Source="ORCID">0000-0003-0448-5992</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jeong</LastName>
            <ForeName>Byong Chang</ForeName>
            <Initials>BC</Initials>
            <Identifier Source="ORCID">0000-0002-5399-2184</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ku</LastName>
            <ForeName>Ja Hyeon</ForeName>
            <Initials>JH</Initials>
            <Identifier Source="ORCID">0000-0002-0391-2342</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Urology, Seoul National University Hospital, Seoul, Korea. kuuro70@snu.ac.kr.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>28</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Investig Clin Urol</MedlineTA>
        <NlmUniqueID>101674989</NlmUniqueID>
        <ISSNLinking>2466-0493</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D012828">Silicones</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055499" MajorTopicYN="Y">Catheter-Related Infections</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015653" MajorTopicYN="N">Cystectomy</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012828" MajorTopicYN="N">Silicones</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001749" MajorTopicYN="Y">Urinary Bladder Neoplasms</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062885" MajorTopicYN="N">Urinary Catheters</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014552" MajorTopicYN="Y">Urinary Tract Infections</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Bladder cancer</Keyword>
        <Keyword MajorTopicYN="Y">Urethral catheter</Keyword>
        <Keyword MajorTopicYN="Y">Urinary tract infection</Keyword>
      </KeywordList>
      <CoiStatement>The authors have nothing to disclose.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>4</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35437959</ArticleId>
        <ArticleId IdType="pmc">PMC9091833</ArticleId>
        <ArticleId IdType="doi">10.4111/icu.20210436</ArticleId>
        <ArticleId IdType="pii">63.e32</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Lo E, Nicolle LE, Coffin SE, Gould C, Maragakis LL, Meddings J, et al.  Strategies to prevent catheter-associated urinary tract infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014;35:464–479.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24709715</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Warren JW, Platt R, Thomas RJ, Rosner B, Kass EH. Antibiotic irrigation and catheter-associated urinary-tract infections. N Engl J Med. 1978;299:570–573.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">210379</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Riley DK, Classen DC, Stevens LE, Burke JP. A large randomized clinical trial of a silver-impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. Am J Med. 1995;98:349–356.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7709947</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tenke P, Kovacs B, Bjerklund Johansen TE, Matsumoto T, Tambyah PA, Naber KG. European and Asian guidelines on management and prevention of catheter-associated urinary tract infections. Int J Antimicrob Agents. 2008;31 Suppl 1:S68–S78.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18006279</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chenoweth CE, Saint S, Martinez F, Lynch JP, 3rd, Fendrick AM. Antimicrobial resistance in Streptococcus pneumoniae: implications for patients with community-acquired pneumonia. Mayo Clin Proc. 2000;75:1161–1168.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11075746</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lederer JW, Jarvis WR, Thomas L, Ritter J. Multicenter cohort study to assess the impact of a silver-alloy and hydrogel-coated urinary catheter on symptomatic catheter-associated urinary tract infections. J Wound Ostomy Continence Nurs. 2014;41:473–480.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4165476</ArticleId>
            <ArticleId IdType="pubmed">24922561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saint S, Veenstra DL, Sullivan SD, Chenoweth C, Fendrick AM. The potential clinical and economic benefits of silver alloy urinary catheters in preventing urinary tract infection. Arch Intern Med. 2000;160:2670–2675.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10999983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Niepa THR.  Electrochemical control of bacterial persister cells [dissertation] Syracuse: Syracuse University; 2014. </Citation>
        </Reference>
        <Reference>
          <Citation>Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med. 2010;7:e1000251. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2844794</ArticleId>
            <ArticleId IdType="pubmed">20352064</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al.  CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol. 2010;63:e1–e37. Erratum in: J Clin Epidemiol 2012;65:351.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20346624</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gould CV, Umscheid CA, Agarwal RK, Kuntz G, Pegues DA. Guideline for prevention of catheter-associated urinary tract infections 2009. Infect Control Hosp Epidemiol. 2010;31:319–326.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20156062</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rupp ME, Fitzgerald T, Marion N, Helget V, Puumala S, Anderson JR, et al.  Effect of silver-coated urinary catheters: efficacy, cost-effectiveness, and antimicrobial resistance. Am J Infect Control. 2004;32:445–450.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15573050</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van den Eijkel E, Griffiths P. Catheter valves for indwelling urinary catheters: a systematic review. Br J Community Nurs. 2006;11:111–112. 114.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16607246</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Magistro G, Zimmermann L, Bischoff R, Westhofen T, Grimm T, Schlenker B, et al.  The natural course of urinalysis after urinary diversion. World J Urol. 2021;39:1559–1567.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32661555</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koie T, Yamamoto H, Okamoto A, Imai A, Iwabuchi I, Yoneyama T, et al.  [Risk factors for surgical site infection in radical cystectomy: efficacy of buried suture by absorbable thread for skin closure] Hinyokika Kiyo. 2009;55:75–78. Japanese.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19301611</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hara N, Kitamura Y, Saito T, Komatsubara S, Nishiyama T, Takahashi K. Perioperative antibiotics in radical cystectomy with ileal conduit urinary diversion: efficacy and risk of antimicrobial prophylaxis on the operation day alone. Int J Urol. 2008;15:511–515.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18422576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kanamaru S, Terai A, Ishitoya S, Kunishima Y, Nishiyama H, Segawa T, et al.  Assessment of a protocol for prophylactic antibiotics to prevent perioperative infection in urological surgery: a preliminary study. Int J Urol. 2004;11:355–363.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15157202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsumoto T, Kiyota H, Matsukawa M, Yasuda M, Arakawa S, Monden K. Japanese guidelines for prevention of perioperative infections in urological field. Int J Urol. 2007;14:890–909.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17880286</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shigemura K, Tanaka K, Matsumoto M, Nakano Y, Shirakawa T, Miyata M, et al.  Post-operative infection and prophylactic antibiotic administration after radical cystectomy with orthotopic neobladder urinary diversion. J Infect Chemother. 2012;18:479–484.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22249689</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stickler DJ, Morris NS, Winters C. Simple physical model to study formation and physiology of biofilms on urethral catheters. Methods Enzymol. 1999;310:494–501.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10547813</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumon H, Hashimoto H, Nishimura M, Monden K, Ono N. Catheter-associated urinary tract infections: impact of catheter materials on their management. Int J Antimicrob Agents. 2001;17:311–316.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11295414</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barford JM, Anson K, Hu Y, Coates AR. A model of catheter-associated urinary tract infection initiated by bacterial contamination of the catheter tip. BJU Int. 2008;102:67–74.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18284413</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim KH, Yoon HS, Yoon H, Chung WS, Sim BS, Lee DH. Febrile urinary tract infection after radical cystectomy and ileal neobladder in patients with bladder cancer. J Korean Med Sci. 2016;31:1100–1104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4901003</ArticleId>
            <ArticleId IdType="pubmed">27366009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suriano F, Gallucci M, Flammia GP, Musco S, Alcini A, Imbalzano G, et al.  Bacteriuria in patients with an orthotopic ileal neobladder: urinary tract infection or asymptomatic bacteriuria? BJU Int. 2008;101:1576–1579.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18070190</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
